Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical hydrocortisone for treatment of chronic anal fissure
IRCT20191224045888N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone in chronic anal fissure (CAF), sponsored by Ardabil University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
hydrocortisone
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on IRCT20191224045888N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191224045888N1.